German Ambassador to India, Walter J Lindner, on Thursday announced that the western European country will recognise the Covaxin Covid-19 vaccine for travel to Germany from June 1.
“Very happy that GER government just decided to recognize WHO-listed Covaxin for travels to GER, starting June 1. This embassy has been pushing very actively for such decision,” he said in a tweet.
The embassy, however, hints at longer waiting periods because of Covid-backlogs at visa sections.
Germany’s decision is a relief to people seeking visas to the European nation as a large number of people in India had gone for Covaxin shots.
“We welcome the recognition by Germany to Covaxin,” Suchitra Ella, Co-Founder and Joint Managing Director of Bharat Biotech, said.
Two days ago, the USFDA (Food and Drug Administration of US) lifted the clinical hold on phase 2/3 trials for the vaccine, prompting the company to resume dosing immediately in the US.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.